PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA

Clinical trials for PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA trials appear

Sign up with your email to follow new studies for PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New 'Double-Target' cell therapy tested for tough leukemia cases

Disease control Recruiting now

This study is testing a new type of CAR-T cell therapy designed to attack leukemia cells using two targets (CD19 and CD22) at once. It aims to see if this approach is safe and effective for patients aged 12-65 whose B-cell acute lymphoblastic leukemia has come back or hasn't resp…

Matched conditions: PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA

Get alerted when new PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA trials appear

New 'Double-Target' cell therapy tested for tough leukemia cases